NEWS

LIMS product deployed by top-five pharma company

Sapio Sciences has licensed its Exemplar LIMS product to one of the top five pharmaceutical companies in the world, to help organise its genetics research.

The pharma company currently produces thousands of samples, which could soon grow into millions in the near future. The software provides straightforward wizards to handle the samples automatically, which may then be tracked using 1D and 2D barcodes. The built in reagent protocols for Illumina and Affymetrix platforms eliminate the need for paper tracking of lab procedures.

If this approach seems to be verging on the ELN market, it was wholly deliberate, according to Kevin Cramer, CEO at Sapio, who says the product also integrates bioinformatics systems. ‘We felt from the beginning that intuitively all these product categories should really be one product. In fact, we are going to extend that definition even further to say that certain analytics results and even clinical trial management should be part of a complete LIMS solution.’

The Exemplar LIMS BioBanking module helps the laboratories of the company, whose name has not been disclosed, to adhere to Good Laboratory Practices regulations and FDA CFP 11 Part 21 patent regulations.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers